D'Alessio A, Fulgenzi CAM, Nishida N, Schonlein M, et al. Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: a real-world study. Hepatology 2022 Mar 21. doi: 10.1002/hep.32468.
PMID: 35313048